Nausea & vomiting in pregnancy (NVP), commonly known as "morning sickness", affects 50-90% of pregnant women.
In most women, the condition manifests between the 4th-7th week after last menstrual period and resolves by the 16th week of gestation.
It manifests in a spectrum of severity from mild nausea to very rare life-threatening symptoms.
The etiology is multifactorial.
The pregnant woman's sense of well-being and her daily activities are greatly affected by nausea and vomiting; the physical and emotional impact often leads to anxiety and worry about the effect of the symptoms on the fetus and reduced job efficiency.

Nausea & Vomiting in Pregnancy Drug Information

Drug Information

Indication: Symptomatic treatment of nausea & vomiting including acute migraine-induced nausea & vomiting in adult...

Indication: Prevention & treatment of nausea, vomiting or vertigo associated w/ motion sickness & other vestibular...

vitamin B1 mononitrate + vitamin B12 + vitamin B6

Indication: Mono- & polyneuropathies (eg, diabetic, alcoholic & toxic neuropathies). Neuritis & neuralgia. Vit...

cyanocobalamin + pyridoxine hydrochloride + thiami...

Indication: Mono- & polyneuropathies, deficiency or raised vit B1, B6 & B12 requi...

vitamin B1 + vitamin B12 + vitamin B6
B Complex Upha
nicotinamide + vitamin B1 + vitamin B12 + vitamin ...
mecobalamin + vitamin B1 + vitamin B6
Becolim 100
D-panthenol + niacinamide + vitamin B1 + vitamin B...
2  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 3 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, Yesterday

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.